31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
Under Arizona law, when a purchaser of a new residential dwelling unit alleges a construction defect...
Read More >
On 27 November 2019, the Romanian Parliament approved a Law on Regulation of Alternative Investment ...
Read More >
Join us for the 12th annual “Selecting Project Delivery Methods & Bidding Public Construction Contr...
Read More >
On August 5, 2020, the Governor of Georgia signed Senate Bill 315 to legislatively overrule a Septem...
Read More >
On August 28, 2019, the amendment to Transitory XI of the social security contribution towards Disab...
Read More >
Now that we have a new Michigan No-Fault insurance law, most people will be disappointed that Auto N...
Read More >